Acquisitions in Guangdong, China

Payoneer has completed its acquisition of China-based licensed payment service provider Easylink Payment Co., Ltd., making Payoneer one of the few foreign platforms licensed to provide online payment services in China. The deal strengthens Payoneer's regulatory footprint and local capabilities in China to better serve SMBs with localized cross-border payment products.

CBC Group, in partnership with Mubadala Investment Company, has completed the US$680 million acquisition of UCB’s mature neurology and allergy product portfolio in China, including brands such as Keppra, Vimpat, Neupro, Zyrtec and Xyzal and a manufacturing site in Zhuhai. The assets have been combined into a new company named NeuroGen Pharma as an anchor platform to build an integrated CNS biopharma business in China and expand capability in neurology and allergy treatments.

Baird Medical Investment Holdings Limited, a Guangzhou-based developer and manufacturer of microwave ablation medical devices, has completed its business combination with ExcelFin Acquisition Corp., a Nasdaq-listed SPAC. The combined public company (PubCo) will trade on Nasdaq under the ticker BDMD; founders and co-sponsor Grand Fortune Capital subscribed to a $4.9 million convertible preferred investment in the company.

DerbySoft, a Dallas-based hotel distribution technology company, has acquired China-based Pkfare to expand into the airline distribution market. The companies will remain independent while integrating certain corporate and technology functions to give each other's customers access to additional services; financial terms were not disclosed.